MetaVia shares surge 17.47% intraday after announcing global patent portfolio for obesity drug DA-1726 ensuring 2041 exclusivity.
ByAinvest
Friday, Feb 13, 2026 10:39 am ET1min read
MTVA--
MetaVia surged 17.47% intraday, with the company announcing a comprehensive global patent portfolio for its obesity drug DA-1726, including 39 granted and pending patents to ensure exclusive rights until 2041. The drug demonstrated 9% weight loss and metabolic benefits in clinical trials, with plans to advance dose titration studies. MetaVia, a clinical-stage biotech firm, focuses on developing innovative therapies for cardiovascular and metabolic diseases, with DA-1726 as its core dual OXM analog agonist asset.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet